A small taste of some findings:
- In the US, period tracker use increased post-Dobbs, despite privacy warnings.
- Technologies designed to empower users can also create risks for fairness, autonomy, and accountability.
- Equity-centered research agendas are essential.

5/8
1
1
7
Vast majority of special issue submissions came from high-income contexts.

Despite FemTech collecting data from millions daily, only ~50% of submissions included empirical data.

FDA recently signaled it may relax regulation of health tech, but we need stronger (not weaker!) safeguards.

6/8
1
0
6
This special issue isn’t anti-tech. It’s about ensuring that innovation serves people’s needs, not just market incentives.

The path forward requires collaboration across technology and health, rigorous evaluation, and an unwavering focus on reproductive health, rights, & justice.

7/8
1
0
9